Trial Profile
Clinical Trials Insight: 700009514
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 30 Nov 2005
Price :
$35
*
At a glance
- Drugs PI-166 (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- Sponsors Progen Pharmaceuticals Limited
- 30 Nov 2005 New trial record.